Greg Macpherson (@gregmacpherson) header
Greg Macpherson (@gregmacpherson) profile picture

“Pharmacist & longevity scientist | Author | Making the 12 Hallmarks of Aging, mitochondria, nutraceuticals & post-viral science actionable for your healthspan

Auckland
Joined March 2008
Greg Macpherson retweeted
Robert and I are thrilled that our gift of over 2 million shares of SpaceX stock will be distributed to children’s Trump accounts in December!   Our initial gift (shares transferring to escrow as we speak) will go to 11 to 17-year-olds who live in zip codes with median family income (MFI) of $57,000 or less, and to those who live in zip codes with too few residents for an MFI to be reported in the census. These families should receive a notice by Monday.    In a few weeks, an additional gift will be finalized for eligible 11 to 17-year-old children in military families serving overseas, children in foster care, and more children whose MFI is $90,000 or less living in counties near our home in the great state of Texas.   Thank you to the incredible team @SpaceX, @Treasury, @IRS, @DellFdn, @GreaterHorizons, @InvestAmerica24, and the legal firms of Morgan Lewis and Gibson Dunn for working over the past few months to make this happen.   We are deeply grateful for the groundbreaking work that Brad Gerstner @altcap and @MichaelDell have done for the long-term financial security for millions of kids.   God Bless America!
3,753
675
36,599
3,623,440
Greg Macpherson retweeted
💋 Did you know the kissing disease virus stays in your body for life? Epstein-Barr virus (EBV) hides in B cells and is linked to multiple sclerosis and certain cancers. 🧬 How does it evade our immune system? 🎬 Discover it in our new animation!
10
4
36
3,933
Greg Macpherson retweeted
When an older heart is transplanted into a younger person, it doesn't stay "old." Vadim Gladyshev's lab shows the heart actually starts aging on the timeline of the body it's now living in — its biological age shifts to match the recipient, not the original donor, at the molecular level. biorxiv.org/content/10.64898…
45
195
39
1,020
44,191
Greg Macpherson retweeted
Beyond the established Shingles vaccine link to some protection from dementia and Alzheimer’s disease, a large natural experiment provides evidence for a small (~10%) reduction in stroke, heart failure, ischemic heart disease, and atrial fibrillation, broadening the association of benefit @NatureMedicine @MaximeTaquet and colleagues nature.com/articles/s41591-0…
37
503
67
1,539
1,007,961
What if most disease is actually caused by infections? Individual infections on their own have been linked to huge increases in diseases we think of as non-infectious. - Flu can increase heart attack risk 6x - Viral encephalitis has been linked to 31x higher Alzheimer’s risk - Some persistent viruses increase certain cancer risks tens of times over. And that’s looking at individual infections one at a time and from the limited research we have. People born around the 1918 flu pandemic later had up to 3x the risk of Parkinson’s. At 3x risk, over 67% of Parkinson’s cases in that generation are attributable to that one viral exposure, let alone every other infection on top. Young children get around 6 to 10 respiratory viral infections every year alone. Most people have already had dozens of infections by childhood, while virtually everyone accumulates multiple lifelong persistent viruses that stay in the body forever (EBV, CMV, HSV-1, VZV, HHV-6, HHV-7). In older adults, COVID was associated with 2.5 to 4.9x higher all-cause mortality after the acute infection. And that’s just one virus. So how much disease would exist if infections simply never happened? Could a huge fraction, even the majority, of disease ultimately be post-infectious or caused by persistent infections? And how much longer would humans live without this accumulated infectious burden?
42
142
19
685
33,717
Your body's hormones and metabolites tell a continuous story — but we've had no way to read it in real time, while moving freely. New paper in Nature Nanotechnology (Gao lab, Caltech) just changed that. 🧵
2
9
33
3,552
Greg Macpherson retweeted
Mitochondria are the powerhouse of the cell — and according to biologist Martin Picard, they’re also the link between biology, health, and the mind. In other words, the foundation of our experience being alive. quantamagazine.org/martin-pi…
5
36
7
219
32,932
Greg Macpherson retweeted
"The world’s largest drugmaker is betting big on preventive medicines" The future of medicine is not just to come up with more treatments, which has been the fixation for pharma companies. It can and should be to prevent diseases, with what I call "prevmeds." We're starting to see a shift. economist.com/business/2026/…
19
110
14
489
61,439
Greg Macpherson retweeted
HUGE breakthrough out today, in arguably the single most neglected aspect of aging, extracellular matrix damage. Top researchers have tried & failed for decades to do this. Massive kudos to Aaron and his team! (Proud to note that Revel is a SENS spinout.) revelpharmaceuticals.com/new…
64
262
55
1,864
531,394
Greg Macpherson retweeted
What if many viruses never truly leave us? Implications of RNA virus persistence for post-acute sequelae and chronic inflammatory syndromes ➡️ A new review challenges the long-held belief that most RNA viruses cause only short-lived infections. Increasing evidence suggests that viral RNA, proteins, and even replication-competent genomes can persist long after the acute illness has resolved. ➡️ This lingering viral footprint may continuously interact with the immune system, driving chronic inflammation, #LongCOVID, and other post-viral syndromes. 1/
11
86
5
261
8,679
Greg Macpherson retweeted
What if preventing dementia starts with preventing viral reactivation? A study of 100M+ people found that recurrent shingles increased dementia risk, while vaccination significantly reduced it. To me, the bigger story isn't shingles.
1
1
3
508
The most effective biohacking tool in the world is avoiding viral infections. Viruses increase the probability of all diseases and death magnitudes of order.
13
153
6
734
30,873
Greg Macpherson retweeted
SARS‑CoV‑2 isn’t “no big deal.” Even mild or asymptomatic infections can increase your risk of heart attacks and stroke, accelerated brain aging, cancer, and Long Covid – a chronic, multi‑organ illness affecting 65–400M people worldwide, with >200 symptoms and >$1T/yr in economic damage.
10
33
841
Greg Macpherson retweeted
LA Times: 'What COVID is teaching doctors about the relationship between viruses and cancer' 'The rapid increase in patients suffering from long COVID supercharged research on post-viral syndromes — the complex collection of lingering symptoms...' latimes.com/science/story/20…
2
179
5
536
9,703
Greg Macpherson retweeted
The long-term cardiovascular risks of SARSCoV2 infection and reinfections Your heart is under silent, cumulative attack from SARSCoV2, and every reinfection can reload/worsen the damage. Here a personal recap of 10 important studies from the last 2 years showing exactly how this virus and its reinfections can/may shape (and shorten) your cardiovascular future. Evidence is clear, long-term, and growing. Print and show your Cardiologist. Let’s connect the dots… 1. Immunothrombosis multi-omics study: 3 months after hospitalisation, long COVID patients still have blood biologically “clot-ready” with persistent endothelial activation and prothrombotic signalling. xitter.gq/HarrySpoelstra/status/… 2. IL-6 & SAA 6-year study: Higher acute-phase IL-6 and SAA levels independently predict cardiovascular events and death up to 6 years later, the initial inflammatory storm leaves a lasting CV mark. xitter.gq/HarrySpoelstra/status/… 3. MIS-C long-term outcomes: Up to 4.5 years later, MIS-C raises cardiovascular disease risk 14× and hypertension 9× in children, with risks still accumulating. xitter.gq/HarrySpoelstra/status/… 4. Viruses & cardiac disease review: SARS-CoV-2 stands out for direct cardiomyocyte invasion + explosive damage + relentless accumulation of risk with every reinfection. xitter.gq/HarrySpoelstra/status/… 5. Mayo PET long COVID study: Persistent cerebral hypometabolism in fatigue/PEM patients still detectable up to 2 years post-infection. xitter.gq/HarrySpoelstra/status/… 6. Reinfection CV outcomes summary: Reinfections worsen cumulative heart damage, arrhythmias, thrombosis, stroke risk and long COVID cardiovascular symptoms. xitter.gq/HarrySpoelstra/status/… 7. Youth reinfection & long COVID study: Reinfection roughly doubles PASC risk, with myocarditis up to 3.6× higher, heart disease ~2× higher and increased thromboembolism. xitter.gq/HarrySpoelstra/status/… 8. Mild infection + reinfection risk: Even mild cases trigger lasting endothelial damage and prothrombotic state (1.5–2× long-term CV risk), each reinfection compounds the burden. xitter.gq/HarrySpoelstra/status/… 9 Mitochondrial dysfunction in long COVID: Persistent mitochondrial dysfunction and suppressed oxidative phosphorylation remain in long COVID, pointing to durable multi-organ impact. xitter.gq/HarrySpoelstra/status/… 10. Cumulative reinfection impact on future CV health: Reinfection stacks additional damage on prior endothelial injury and inflammation, increasing lifetime risk of heart failure, arrhythmias, thrombosis and accelerated cardiovascular disease. xitter.gq/HarrySpoelstra/status/… 11. Extra, my earlier general reminder post on this exact theme: xitter.gq/HarrySpoelstra/status/… ‼️Overall convergence across the studies: Immunothrombosis, acute inflammation markers, direct invasion, endothelial damage, and mitochondrial issues create lasting CV vulnerability that reinfections can keep reloading. #L0ngC0vid The pattern is very clear. Fewer infections = lower lifetime cardiovascular risk. You only have one heart. Protect it! #AvoidSars2 #AvoidReinfections #CleanAir #VaccineUpdated
🚨GENERAL REMINDER: YOU ONLY HAVE ONE HEART, TREAT IT WITH RESPECT! Reinfections aren't harmless "boosters", they stack the deck against your HEART, turning one hit into compounding long-term cardiovascular risks. ➡️3 important and recent articles (from 2025–2026) providing the strong evidence that SARS-CoV-2 reinfections increase risks of long COVID, including cardiovascular complications like myocarditis, arrhythmias, heart disease, thromboembolism, and related issues( There're more!!): ➡️1. Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study. Published in The Lancet Infectious Diseases (2026). This large retrospective study of nearly 500,000 youth found reinfection roughly doubles the risk of long COVID/PASC overall (RR 2.08), with elevated risks for myocarditis (up to 3.6×), arrhythmias, heart disease, thromboembolism, chest pain, and other cardiovascular signs/symptoms, even in vaccinated individuals. thelancet.com/journals/lanin… ➡️2. Long COVID Syndrome Prevalence in 2025 in an Integral Healthcare Consortium in the Metropolitan Area of Barcelona: Persistent and Transient Symptoms. Published in Vaccines (MDPI, 2025). This real-world study showed long COVID prevalence was 3–10 times higher in people with three or more infections vs. one, alongside a post-pandemic doubling of thrombotic events (cardiovascular-related clots) across populations, linking reinfections to worsened persistent symptoms including cardiovascular sequelae. pmc.ncbi.nlm.nih.gov/article… ➡️3. Cardiovascular damage and comorbidities related to long COVID: pathomechanisms, prevention, and therapy. Published in Physiological Research (2025). This review explicitly states reinfections can trigger de novo long COVID or exacerbate its severity, contributing to persistent cardiovascular risks like heart failure, dysrhythmias, myocardial infarction, and stroke, building on evidence of cumulative damage from repeat SARS-CoV-2 exposures. pmc.ncbi.nlm.nih.gov/article… ➡️So: 1. Reinfection worsens endothelial dysfunction (already impaired from prior COVID), raising cardiac event risks, especially in those with pre-existing atherosclerosis or CV factors, 2. Repeat infections cumulatively boost long COVID odds, including cardiovascular manifestations (e.g, myocarditis, arrhythmias, heart conditions 3× higher in some cohorts), 3. Studies show 1.35–2× higher long COVID risk after reinfection vs. single infection. One large pediatric analysis found ~2× higher PASC (including heart-related) post-reinfection in Omicron era. 4. Experts note each infection adds damage, accelerating vascular aging, plaque issues, and overall CV burden, even mild cases. The reminder: Reinfections aren't harmless "boosters"—they stack the deck against your heart, turning one hit into compounding long-term cardiovascular risks. YOU ONLY HAVE ONE HEART, TREAT IT WITH RESPECT! PLEASE: #AVOIDREINFECTIONS #AVOIDSARS2 #HEARTHEALTH #CLEANAIR
19
383
35
727
34,797
Greg Macpherson retweeted
What if viruses don’t need to infect the brain to damage it? ➡️ A growing body of evidence suggests that viral proteins themselves can act as neurotoxins, triggering long-lasting neurological symptoms even when little or no virus is present in the CNS. 1/
7
97
2
243
11,211
A concept I keep returning to: Personal Viral Burden. Not the last cold you caught, but the lifelong cumulative load of the viruses that never leave: CMV, EBV, HHV-6, VZV, HSV. Why PVB belongs in the longevity conversation. These latent viruses live in your cells for life and reactivate now and then. By 70, CMV is detectable in essentially everyone, and CMV-specific T cells can swell to a quarter or more of your CD8 pool. That is important immune bandwidth spent guarding old enemies. 2025 work in older adults links higher latent viral burden to more inflammation and worse cardiovascular outcomes. The cost is not any single infection. It is decades of low-grade immune tax that compounds quietly. Thread two: immunometabolism. 2025 and 2026 research shows aging T cells shift how they burn fuel, lose metabolic flexibility, and respond worse to new threats and to vaccines. How an immune cell powers itself shapes how well it fights. Thread three: a May 2026 Frontiers in Immunology multi-omics study found long COVID carries a persistent signature of suppressed mitochondrial OXPHOS across tissues, out to 12 months. The cellular power supply stays dialled down post infection. The connective tissue across all three: immune resilience is deeply intertwined with metabolism. Mitochondria fuel T cell function. Keeping the power plants healthy helps you defend better against both new infections and reactivating old ones. Which is why I treat viral burden as a longevity variable, not just an infection-by-infection event. It is worth thinking about, and increasingly worth measuring.
1
3
205
Taurine was the longevity darling of 2023 (Singh et al., Science). Here is the uncomfortable update worth sitting with: a 2025 NIH replication in Science found taurine levels often rise, not fall, with age. The follow-up from de Cabo and colleagues, plus a 2025 Aging Cell human study, found circulating taurine was not reliably tied to muscle, strength or mitochondrial function. Does that make taurine useless? No. It means the deficiency-drives-aging claim was premature. I still take 1 to 2g a day for its cardiovascular and metabolic benefits. Contrast that with NMN, where human data keeps firming up. A January 2026 randomised trial in 65 adults showed 14 days of NMN roughly doubled circulating NAD+, comparable to NR, with a clean safety record up to 1,250mg a day. And fucoidan, the sulphated polysaccharide from brown seaweed, activated SIRT6 and extended male mouse lifespan by 13% in 2025 Rochester work. Human stem cell mobilisation data goes back to Irhimeh (2007). I fish the same oceans it comes from. The pattern that everyone in the space needs to be mindful of ... separate the mouse headline from the human evidence, then watch what survives. NMN and fucoidan are aging well. Taurine's longevity halo has dimmed even as its other benefits stand.
106
Epigenetic alterations are the Hallmark of Aging (Lopez-Otin et al., Cell 2023) I find most hopeful when it comes to the potential for significant longevity outcomes. Your DNA barely changes across life. What changes is how it is read. And reading is something you can influence. Think of your genome as the hardware and the epigenome as the software: DNA methylation, histone marks and chromatin structure decide which genes are switched on or off. With age that software drifts. The right genes get muted, the wrong ones get noisy. This drift is exactly what biological age tests read. Epigenetic clocks (Horvath, PhenoAge, GrimAge) measure methylation patterns to estimate how fast you are aging, often more honestly than the candles on your cake. Here is the part that changes everything: it is reversible. Partial reprogramming with Yamanaka factors can lower epigenetic age in cells, and far more practically, lifestyle moves these clocks too. A 2026 study showed six months of endurance training reversed GrimAge in middle-aged adults. What helps day to day: feed methylation (folate and B12 are methyl donors, which is why they sit in my Cel1), move regularly, protect sleep, and cut the two big accelerators, smoking and excess alcohol, both of which age the methylome fast. The lever I lean on is fasting. Prolonged fasting drives autophagy and stem cell renewal (Valter Longo's work), and the 4-day water fast I run each quarter is my deliberate attempt to reset some of that accumulated epigenetic noise. Our 2025 trial (Macpherson et al., Aging, PMID 40096467) measured epigenetic clocks directly and saw biological age fall over twelve months. The headline for me is not the number. It is that this hallmark bends positively from both lifestyle and augmenting lifestyle with clinically validated supplementation.
80
Personal Viral Burden update: HSV-1 just gained another mechanistic link to Alzheimer's. New 2025 research shows viral proteins activate transposable elements in neurons, accelerating brain degeneration. Pooled data from 2025 meta-analysis: HSV1/2 clinical episode increases all-cause dementia hazard by ~36% (HR 1.36, 95% CI 1.01-1.83). Antiviral prescriptions (valacyclovir, acyclovir) associated with lower AD incidence, especially in women and those over 75. Counterpoint: a 2025 randomised trial of antivirals in early Alzheimer's failed to slow progression. Prevention may be easier than reversal. Treat the infection early; do not wait until cognitive decline is established. Immunometabolism: T cells and macrophages run on mitochondria. Aged T cells show reduced respiratory reserve and impaired metabolic flexibility. The senescence-metabolism axis is now an active therapeutic target. Long COVID: 2026 Frontiers in Immunology multi-omics found sustained down regulation of oxidative phosphorylation in PBMCs out to 12 months post-infection. Three practical levers: get the shingles vaccine (Eyting et al., Nature 2025: ~20% lower dementia risk in recipients). Support mitochondrial function relentlessly. Treat HSV reactivations early, not late. The immune system is a metabolic organ that happens to do defence. Anything that supports mitochondrial health supports immune resilience.
180